Cosopt Drop Eye 2/0.5% 5ML

Description

Indications

Cosopt Drop Eye 2/0.5% 5ML is primarily indicated in conditions like Ocular hypertension, Open-angle glaucoma, Pseudoexfoliative glaucoma, Raised iop.

Side Effects

the symptomatic adverse reactions produced by Cosopt Drop Eye 2/0.5% 5ML are more or less tolerable and if they become severe, they can be treated symptomatically, these include Inflammation, Nausea, Urticaria, Burning, Asthenia, Lacrimation, Conjunctivitis, Photophobia, Ocular irritation, Vision disturbances, Tearing, Keratitis, Stinging, Local allergies, Xerophthalmia, Rarely hypersensitivity reactions.

Contraindication

Cosopt Drop Eye 2/0.5% 5ML is contraindicated in conditions like Renal impairment, Hyperchloremic acidosis.

Warning

The preservative in this medication may be absorbed by soft contact lenses; therefore, it is recommended that soft contact lenses not be worn while using this medication. Cosopt Drop Eye 2/0.5% 5ML should not be administered to patients with carbonic anhydrase inhibitor hypersensitivity. In addition, since Cosopt Drop Eye 2/0.5% 5ML is a sulfonamide derivative, it should not be used in patients with sulfonamide hypersensitivity. Topical administration of Cosopt Drop Eye 2/0.5% 5ML can result in systemic absorption. In sulfonamide-sensitive patients, administration of sulfonamides by any route can precipitate a possibly severe reaction. Its use as a single agent is insufficient for the management of closed-angle glaucoma. The use of multiple dose containers of ophthalmic products has been associated with bacterial keratitis. Inadvertent contamination of the product may occur if the patient has an ocular infection, or corneal abrasion. If there is any damage to the ocular epithelial surface Cosopt Drop Eye 2/0.5% 5ML should be used with caution. It should be used with caution in patients with hepatic disease. It is classified as pregnancy category C. Should be use during pregnancy only if the benefits outweigh the possible risks to the fetus. Cuation:- Systemic alesorption follows topical application; history of renal calculi; chronic corneal defects, history of intra-ocular surgury.